🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Hemab Therapeutics Holdings, Inc. (COAG)
NASDAQ: COAG · Real-Time Price · USD
39.29
-0.57 (-1.43%)
Nov 20, 2026, 4:00 PM EST - Market closed

COAG Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024
Period Ending
Nov '26 Dec '25 Dec '24
1,836--
Market Cap Growth
---
Enterprise Value
1,407--

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024
Period Ending
Nov '26 Dec '25 Dec '24
Debt / Equity Ratio
0.000.010.02
Net Debt / Equity Ratio
-1.00-1.00-0.98
Net Debt / EBITDA Ratio
4.312.641.72
Net Debt / FCF Ratio
4.803.001.88
Quick Ratio
33.3417.6213.45
Current Ratio
33.8618.0313.95
Return on Equity (ROE)
--46.99%-
Return on Assets (ROA)
-21.11%-43.92%-50.59%
Return on Capital Employed (ROCE)
-23.20%-38.10%-56.20%
SEC Filings: 10-K · 10-Q